期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 8, 期 1, 页码 43-48出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00281
关键词
LpPLA(2); bicyclo[1.1.1]pentane; bioisostere; darapladib; cardiovascular disease; physicochemical
资金
- GlaxoSmithKline RD, Stevenage
We describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA(2) inhibitors to act as bioisosteric phenyl replacements. An efficient synthesis to the target compounds was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation. Potency, physicochemical, and X-ray crystallographic data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and positively impacted on the physicochemical profile.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据